Decision and Details
Receipt of the Special Investigation Committee’s investigation report
To determine the facts, details and root causes of the suspected improper transactions and misconduct at the marketing center of the subsidiary concerned, and to prevent recurrence.
The announcement date for the financial results summary for the fiscal year ended March 2026 has not been determined. The results will be disclosed promptly once finalized. Other effects on financial results and financial condition are not disclosed.
| Item | Details |
|---|---|
| Matter Covered | Receipt of the Special Investigation Committee’s investigation report |
| Implementation Date | 12 June 2026 (date on which the investigation report was received) |
| Impact on Business Performance | The announcement date for the financial results summary for the fiscal year ended March 2026 has not been determined. The results will be disclosed promptly once finalized. Other effects on financial results and financial condition are not disclosed. |
| Reason | To determine the facts, details and root causes of the suspected improper transactions and misconduct at the marketing center of the subsidiary concerned, and to prevent recurrence. |
| Related previous disclosures | “Notice Regarding the Establishment of a Special Investigation Committee in Response to Suspected Improper Transactions and Suspected Misconduct at a Consolidated Subsidiary of the Company,” dated 3 April 2026, and “Notice Regarding the Announcement of the Financial Results Summary for the Fiscal Year Ended March 2026 Taking More Than 50 Days After the Fiscal Year-End,” dated 30 April 2026 |
| Future plans | The investigation report will be promptly released after certain information has been withheld from disclosure from the perspective of protecting privacy, personal information and confidential information. Following finalization of the financial results, the financial results summary for the fiscal year ending March 2026 will be promptly released, and specific measures to prevent recurrence will be formulated based on the recommendations in the investigation results. Further details will be announced once the measures have been decided. |
Items this document does not state (6)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To determine the facts and root causes of the suspected improper transactions and misconduct at the marketing center of the subsidiary concerned, and to prevent recurrence.